GILEAD SCIENCES SL
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- $95.8B
ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)
- Conditions
- Pulmonary Hypertension
- First Posted Date
- 2004-09-14
- Last Posted Date
- 2010-03-08
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 372
- Registration Number
- NCT00091598
- Locations
- 🇺🇸
University of Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
🇺🇸Brentwood Biomedical Research Institute, Los Angeles, California, United States
🇺🇸Medical College of Georgia, Augusta, Georgia, United States
Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine
- Conditions
- Angina
- First Posted Date
- 2004-09-10
- Last Posted Date
- 2009-11-26
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 500
- Registration Number
- NCT00091429
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2004-03-12
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT00003338
- Locations
- 🇺🇸
Nuclear Physicians Ltd., Cuyahoga Falls, Ohio, United States
🇦🇹Innsbruck Universitaetsklinik, Innsbruck, Austria
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2004-03-12
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT00003337
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸University of Texas- Houston Medical School, Houston, Texas, United States
Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure
- Conditions
- Heart Failure, Congestive
- Interventions
- First Posted Date
- 2004-02-18
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 175
- Registration Number
- NCT00077948
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
🇺🇸University of Colorado, Denver, Colorado, United States
Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B
- Conditions
- Chronic Hepatitis B
- First Posted Date
- 2003-10-17
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 48
- Registration Number
- NCT00071201
- Locations
- 🇺🇸
Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California, United States
Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgG
- Conditions
- Non-Hodgkin's LymphomaLymphoma, B-Cell
- First Posted Date
- 2003-05-28
- Last Posted Date
- 2021-08-19
- Lead Sponsor
- Gilead Sciences
- Registration Number
- NCT00061425
Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma
- Conditions
- Non-Hodgkins Lymphoma
- First Posted Date
- 2003-02-13
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 27
- Registration Number
- NCT00054834
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure"
- Conditions
- Heart Failure, Congestive
- Interventions
- First Posted Date
- 2003-01-09
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 1800
- Registration Number
- NCT00051285
Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension
- Conditions
- Pulmonary Hypertension
- First Posted Date
- 2002-09-30
- Last Posted Date
- 2009-04-16
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT00046319
- Locations
- 🇺🇸
University of California San Diego Medical Center, San Diego, California, United States
🇺🇸Los Angeles County Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸Rush Presbyterian, Chicago, Illinois, United States